Limitations of the study include the relatively small sample size for long-term follow-up and the potential for bias ... long-term treatment for patients with moderate to severe plaque psoriasis.” ...

Secukinumab delivers sustained efficacy and quality of life improvements in pediatric generalized pustular psoriasis (GPP).

No clinically meaningful differences were observed in the efficacy, safety, pharmacokinetics, and immunogenicity of proposed biosimilar and ustekinumab for the treatment of moderate to severe plaque ...

Psoriasis is more than just a skin condition – it’s an autoimmune disorder that can manifest as scales, spots, or even ...

The company had $583.3 million in cash as of September 30th of 2024; Enough cash to fund its operations until the end of 2027 ...

And if you have psoriasis — an immune-mediated condition that causes scaly patches and raised plaques — painful ... The AAD recommends testing it out on a small area first to see how your ...

The most important thing you can do to manage psoriasis is work with a dermatologist to create a treatment plan that’s right for you. However, in addition to working with a dermatologist ...

According to the manufacturer, the spray version of this drug can help relieve symptoms faster than other versions. In studies, 8 out of 10 patients with moderate-to-severe plaque-type psoriasis were ...

Nov. 12, 2024 — Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other ...

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

Psoriasis is a common, chronic inflammatory dermatosis, and patients with psoriasis often develop nail involvement. It is ...

He also had scaling plaques on his scalp ... A clinical diagnosis was made of psoriasis and he was prescribed clobetasol propionate ointment with salicylic acid 6% in petrolatum that should ...